Background: Cases of allergy to Cannabis sativa have occasionally been reported, but both the allergenic profile and eventual cross-reactivity pattern remain unknown. Objective: To analyze the allergenic profile of a population of patients from Spain sensitized to C. sativa and to characterize the C. sativa leaf extract. Methods: A total of 32 subjects were enrolled in the study: group A, 10 individuals sensitized to tomato, reporting reactions by contact or inhalation to Cannabis; group B, 14 individuals sensitized to tomato, without reactions to Cannabis; group C, 8 individuals not sensitized to tomato and without reactions to Cannabis. Sensitivity to Cannabis, tomato and peach peel, Platanus hybrida and Artemisia vulgaris pollen extracts was measured by skin tests and specific IgE. Individual immunoblots and inhibition experiments with a pool of sera were conducted. Results: All tomato-sensitized subjects (and 1 negative) had positive skin tests to C. sativa leaves and hashish. Specific IgE to C. sativa and peach peel was more common than to tomato. Immunoblot experiments showed 2 prominent bands of 10 and 14 kDa and 2 weakly recognized bands of 30 and 45 kDa. Tomato, peach and A. vulgaris extracts inhibited most of the bands present in C. sativa. P. hybrida inhibited only the high-molecular-weight bands. Conclusion: Sensitization to C. sativa with or without symptoms is frequent among patients in Spain sensitized to tomato. C. sativa leaves are a potential allergenic source and their allergens may cross-react with other allergenic sources from plants (fruit peels and pollen).

Keywords:
Allergy, Cannabis sativa, Tomato, Lycopersicon esculentum, Peach, Artemisia vulgaris, Platanus hybrida, Cross-reactivity, Contact urticaria
1.
Clarke RC: Botany of the genus Cannabis; in Ranalli P (ed): Advances in Hemp Research. New York, Haworth Press, 1999, pp 1–18.
2.
Clarke RC: Hashish! Los Angeles, Red Eye Press, 1998.
3.
Liskow B, Liss JL, Parker CW: Allergy to marihuana. Ann Intern Med 1971;75:571–573.
4.
Añibarro B, Fontela JL: Allergy to marihuana. Allergy 1996;51:200–201.
5.
Lindemayr H, Jager S: Occupational immediate type allergy to hemp pollen and hashish (in German). Derm Beruf Umwelt 1980;28:17–19.
6.
Majmudar V, Azam NA, Finch T: Contact urticaria to Cannabis sativa. Contact Dermatitis 2006;54:127.
7.
Pajarón Fernández MJ, Bartolomé B, Orts Jiménez D, Carnero González L, Canto Vizcaíno E, Aldecoa Martínez MD: Alergia a planta de marihuana (abstract). Alergol Inmunol Clin 2005;20(extra 2):186.
8.
Perez JA Jr: Allergic reaction associated with intravenous marijuana use. J Emerg Med 2000;18:260–261.
9.
Singh AB, Kumar P: Aeroallergens in clinical practice of allergy in India: an overview. Ann Agric Environ Med 2003;10:131–136.
10.
Stokes JR, Hartel R, Ford LB, Casale TB: Cannabis (hemp) positive skin tests and respiratory symptoms. Ann Allergy Asthma Immunol 2000;85:238–240.
11.
Cabezudo B, Recio M, Sánchez-Laulhé JM, Trigo MM, Toro FJ, Polvorinos F: Atmospheric transportation of marihuana pollen from North Africa to the Southwest of Europe. Atmospheric Environ 1997;31:3323–3328.
12.
Freeman GL: Allergic skin test reactivity to marijuana in the Southwest. West J Med 1983;138:829–831.
13.
Stadtmauer G, Beyer K, Bardina L, Sicherer SH: Anaphylaxis to ingestion of hempseed (Cannabis sativa). J Allergy Clin Immunol 2003;112:216–217.
14.
Vidal C, Fuente R, Iglesias A, Saez A: Bronchial asthma due to Cannabis sativa seed. Allergy 1991;46:647–649.
15.
Zuskin E, Mustajbegovic J, Schachter EN: Follow-up study of respiratory function in hemp workers. Am J Ind Med 1994;26:103–115.
16.
Jiménez Díaz C, López García E, Lahoz F, Ramírez Güedes J, Ales JM: Asma y fibrosis (consideraciones sobre enfermos del cáñamo y esparto). Rev Clin Esp 1966;103:182–188.
17.
Larramendi CH, Ferrer A, Huertas AJ, Garcìa-Abujeta JL, Andreu C, Telle R, Cerdà MT, Bartra J, Lavin JR, Pagán JA, López-Matas MA, Fernández-Caldas E, Carnés J: Sensitization to tomato peel and pulp extracts in the Mediterranean Coast of Spain. Prevalence and co-sensitization with aeroallergens. Clin Exp Allergy 2008;38:169–177.
18.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680–685.
19.
Morales Rubio C, Durá Calatayud M, Bartolomé B, Peláez Hernández A, Mencía Sánchez G, Ojeda González L: Alergia a planta de Cannabis sativa (abstract). J Investig Allergol Clin Immunol 2006;16(suppl 2):112–113.
20.
Wright D, Sathe N, Spagnola K: State Estimates of Substance Use from the 2004–2005 National Surveys on Drug Use and Health. DHHS Publication No. SMA 07-4235, NSDUH Series H-31. Rockville, Md., Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2007.
21.
Tetrault JM, Crothers K, Moore BA, Mehra R, Concato J, Fiellin DA: Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007;167:221–228.
22.
Vannacci A, Giannini L, Passani MB, Di Felice A, Pierpaoli S, Zagli G, Fantappie O, Mazzanti R, Masini E, Mannaioni PF: The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of Guinea pig mast cells: involvement of nitric oxide and eicosanoids. J Pharmacol Exp Ther 2004;311:256–264.
23.
Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tuting T, Zimmer A: Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 2007;316:1494–1497.
24.
Tanaka H, Degawa M, Kawata E, Hayashi J, Shoyama Y: Identification of Cannabis pollens using an allergic patient’s immunoglobulin E and purification and characterization of allergens in Cannabis pollens. Forensic Sci Int 1998;97:139–153.
25.
Fernández Rivas M: Reactividad cruzada en frutas y vegetales. Allergol Immunopathol (Madr) 2003;31:141–146.
26.
Pastorello EA, Pravettoni V, Farioli L, Rivolta F, Conti A, Ispano M, Fortunato D, Bengtsson A, Bianchi M: Hypersensitivity to mugwort (Artemisia vulgaris) in patients with peach allergy is due to a common lipid transfer protein allergen and is often without clinical expression. J Allergy Clin Immunol 2002;110:310–317.
27.
Swoboda I, Grote M, Verdino P, Keller W, Singh MB, De Weerd N, Sperr WR, Valent P, Balic N, Reichelt R, Suck R, Fiebig H, Valenta R, Spitzauer S: Molecular characterization of polygalacturonases as grass pollen-specific marker allergens: expulsion from pollen via submicronic respirable particles. J Immunol 2004;172:6490–6500.
28.
Ibarrola I, Arilla MC, Martinez A, Asturias JA: Identification of a polygalacturonase as a major allergen (Pla a 2) from Platanus acerifolia pollen. J Allergy Clin Immunol 2004;113:1185–1191.
29.
Lauer I, Miguel-Moncin MS, Abel T, Foetisch K, Hartz C, Fortunato D, Cistero-Bahima A, Vieths S, Scheurer S: Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3. Clin Exp Allergy 2007;37:261–269.
30.
Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E, Asero R, van Leeuwen A, Bohle B, Ma Y, Ebner C, Rigby N, Sancho AI, Miles S, Zuidmeer L, Knulst A, Breiteneder H, Mills C, Hoffmann-Sommergruber K, van Ree R: Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol 2006;118:481–488.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.